Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1108 per EA under NDC 16729020101. Its NADAC has been published 495 times since Nov 30, 2016.
FDA first approved this application on Dec 30, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729020101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202557FDA Approved
12/30/2014
TE Code
AB
On Market Since
11/14/2016
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 495 times since Nov 30, 2016, and over the history we have for it it has declined 84.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1108 per EA |
|---|---|
| All-time high | $0.7271 (Dec 14, 2016) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1212 |
| 52-week low | $0.1108 |
| Median price | $0.2475 |
| Average price | $0.2786 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 495 |
| Tracking since | Nov 30, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
-4.5%
1Y
-6.8%
3Y
-25.1%
5Y
-52.8%
All
-84.8%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1108 per EA (NDC 16729020101), effective May 20, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 84.8%. It has been tracked across 495 weekly CMS publications since Nov 30, 2016.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Nov 30, 2016, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.7271 (Dec 14, 2016), with a median of $0.2475 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 7.5 MG TABLET, is $0.1039 per EA — about 6% below BUSPIRONE HCL 7.5 MG TABLET.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 16729020101) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.